|
시장보고서
상품코드
1972946
퀴닌 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Quinine Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계 퀴닌 시장 규모는 예측 기간 동안 상당한 성장을 보일 것으로 예상되며, 2026년 25억 달러에서 2033년까지 6.1%의 연평균 복합 성장률(CAGR)로 2033년까지 41억 달러로 확대될 것으로 예측됩니다. 이러한 성장은 말라리아의 확산, 퀴닌의 치료 효과에 대한 인식 증가, 다리 경련 및 기타 건강 상태를 관리하는 데 있어 퀴닌의 사용이 확립된 데 기인합니다.
시장 인사이트
퀴닌은 키나무 껍질에서 추출한 알칼로이드이며, 수십년동안 말라리아 치료의 근간이 되어 왔습니다. 그 효능은 말라리아 치료뿐만 아니라 근육 경련 및 기타 질병과 관련된 증상 완화에도 기여하고 있습니다. 시장에서는 천연 유래 및 식물 유래 의약품으로의 전환이 진행되고 있으며, 이에 따라 퀴닌은 기존 의료와 대체의학 분야에서 그 중요성이 더욱 커지고 있습니다.
경구, 근육 내, 정맥 내 투여 등 제형과 투여 방법의 발전으로 환자의 복약 순응도가 향상되고 치료 접근성이 확대되고 있습니다. 또한, 전 세계 병원, 진료소, 의료 서비스 제공업체 수요 증가는 시장의 꾸준한 성장세를 뒷받침하고 있습니다.
시장 성장 촉진요인
퀴닌 시장은 다음과 같은 여러 요인에 의해 추진되고 있습니다.
- 말라리아의 높은 발병률: 열대 및 아열대 지역, 특히 아프리카와 아시아 일부 지역에서는 말라리아가 여전히 풍토병으로 만연해 있습니다. 퀴니네는 특히 중증 말라리아 환자나 다른 항말라리아제에 내성이 확인된 환자에서 중요한 치료 옵션으로 남아있습니다.
- 다리 경련 관리: 퀴닌은 야간이나 문제가 되는 다리 경련 치료에 효과적이기 때문에 특히 노인과 운동선수를 대상으로 의료진에 의한 채용이 증가하고 있습니다.
- 의료 인프라 확충: 전 세계 병원, 진료소, 진단 시설의 확대로 퀴닌기반 치료에 대한 접근성이 향상되어 시장의 지속적인 성장을 뒷받침하고 있습니다.
- 혁신적인 제형 기술: 새로운 제형과 투여 방법의 도입으로 효능과 환자의 복약 순응도를 향상시켜 시장 채택을 촉진하고 있습니다.
비즈니스 기회
퀴닌 시장에는 사업 확장을 위한 여러 길이 열려 있습니다.
- 제형 혁신 : 서방형 정제, 병용요법 등 첨단 제형 개발은 환자의 복약 순응도 향상과 제품 차별화로 이어집니다.
- 신흥 시장에서의 확장: 아시아태평양, 라틴아메리카, 아프리카의 의료 인프라의 급속한 발전은 신규 진출기업에게 큰 성장 기회를 제공합니다.
- 제휴 및 파트너십: 제조업체와 연구기관과의 협력을 통해 제품 개발 및 지역 내 보급을 가속화할 수 있습니다.
- 일반의약품 분야로의 응용: 근육 이완 효과를 목적으로 하는 건강제품에 퀴닌을 활용하는 것은 소비자용 의약품 브랜드의 새로운 수익원이 될 수 있습니다.
지역별 분석
북미는 잘 구축된 의료 시스템과 근육경련 관리 요법에 대한 수요 증가로 안정적인 시장을 유지하고 있습니다. 유럽에서는 고령화와 치료 대안에 대한 인식 개선이 지속적인 성장에 기여하고 있습니다.
아시아태평양은 높은 말라리아 유병률, 의료 인프라 개선, 가처분 소득 증가를 배경으로 예측 기간 동안 가장 높은 성장률을 나타낼 것으로 예측됩니다. 라틴아메리카와 중동 및 아프리카도 공중보건 정책과 예방 및 치료법에 대한 인식이 높아짐에 따라 중요한 기여를 할 수 있는 지역이 될 것입니다.
주요 기업
세계 퀴닌 시장은 경쟁이 치열하며, 주요 기업들이 혁신을 통해 시장 확대를 위해 노력하고 있습니다. 대표적인 시장 진출기업은 다음과 같습니다.
- Aecochem Corp
- Haihang Industry Co. Ltd.
- Actavis
- Shreeji Pharma International
- Wockhardt
- Vital Labs
- Trademax Pharmaceuticals & Chemicals
- Van Wankum Ingredients
- Hangzhou Dayang Co. Ltd.
- IS Chemical Technology Ltd.
- Leocorno Enterprises
- Bickford & Sons
- Fever-Tree
- Schweppes
- Chempro Pharma Private Limited
이들 기업은 시장에서의 입지를 강화하고 전 세계적으로 증가하는 퀴닌수요에 대응하기 위해 전략적 제휴, 제품 개발, 지역 확장에 주력하고 있습니다.
시장 세분화
퀴닌 시장은 유형, 용도, 투여 방법, 최종 사용자, 지리적 범위에 따라 시장이 세분화됩니다.
유형별:
- 200mg
- 300mg
- 기타
용도별:
- 다리 경련
- 말라리아
- 기타
투여 경로별:
- 경구 투여
- 근육내 투여
- 정맥 투여
- 기타
최종 사용자별:
- 병원
- 진료소
- 기타
지역별:
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 기회
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter의 Five Forces 분석
- 러시아·우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
- 현재 가격과 향후 예측, 2025년-2033년
- 가격 영향요인
제3장 세계의 퀴닌 시장 전망, 2020년-2033년
- 세계의 퀴닌 시장 전망, 유형별, 금액(10억 달러), 2020년-2033년
- 200mg
- 300mg
- 기타
- 세계의 퀴닌 시장 전망, 용도별, 금액(10억 달러), 2020년-2033년
- 다리 경련
- 말라리아
- 기타
- 세계의 퀴닌 시장 전망, 투여량별, 금액(10억 달러), 2020년-2033년
- 경구투여
- 근육내 투여
- 정맥내 투여
- 기타
- 세계의 퀴닌 시장 전망, 최종사용자별, 금액(10억 달러), 2020년-2033년
- 병원
- 클리닉
- 기타
- 세계의 퀴닌 시장 전망, 지역별, 금액(10억 달러), 2020년-2033년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미 퀴닌 시장 전망, 2020년-2033년
제5장 유럽 퀴닌 시장 전망, 2020년-2033년
제6장 아시아태평양 퀴닌 시장 전망, 2020년-2033년
제7장 라틴아메리카 퀴닌 시장 전망,2020-2033년
제8장 중동 및 아프리카 퀴닌 시장 전망, 2020년-2033년
제9장 경쟁 구도
- 기업대 부문 히트맵
- 기업의 시장 점유율 분석, 2025년
- 경쟁 대시보드
- 기업 개요
- Aecochem Corp
- Haihang Industry Co. Ltd.
- Actavis
- Shreeji Pharma International
- Wockhardt
- Vital Labs
- Van Wankum Ingredients
- Hangzhou Dayang Co. Ltd.
- IS Chemical Technology Ltd.
- Leocorno Enterprises
제10장 부록
LSH 26.04.01The global Quinine Market is anticipated to grow significantly over the forecast period, expanding from $2.5 billion in 2026 to $4.1 billion by 2033, representing a CAGR of 6.1%. This growth is attributed to the increasing prevalence of malaria, rising awareness about quinine's therapeutic benefits, and its established use in managing problematic leg cramps and other health conditions.
Market Insights
Quinine, an alkaloid extracted from the bark of the Cinchona tree, has been a cornerstone in the treatment of malaria for decades. Its effectiveness extends beyond malaria, addressing symptoms related to muscle cramps and other medical conditions. The market is witnessing a shift toward natural and plant-derived medicines, further boosting quinine's relevance in both conventional and alternative healthcare sectors.
Advancements in formulation and administration methods, including oral, intramuscular, and intravenous applications, are enhancing patient compliance and expanding treatment accessibility. Moreover, the growing demand from hospitals, clinics, and healthcare providers worldwide underpins the market's steady growth trajectory.
Market Drivers
The quinine market is propelled by several factors:
- High Malaria Prevalence: Malaria remains endemic in tropical and subtropical regions, particularly in Africa and parts of Asia. Quinine remains a critical therapeutic option, especially for severe malaria cases and instances of resistance to other antimalarial drugs.
- Leg Cramps Management: Quinine's effectiveness in treating nocturnal and problematic leg cramps has increased its adoption among healthcare professionals, particularly for elderly patients and athletes.
- Growing Healthcare Infrastructure: Expansion of hospitals, clinics, and diagnostic facilities globally has improved access to quinine-based treatments, supporting consistent market growth.
- Innovative Pharmaceutical Formulations: Introduction of new dosage forms and administration methods improves efficacy and patient adherence, boosting market adoption.
Business Opportunities
The quinine market presents multiple avenues for business expansion:
- Formulation Innovation: Development of advanced dosage forms, such as extended-release tablets and combination therapies, can enhance patient compliance and differentiate products.
- Expansion in Emerging Markets: Rapidly developing healthcare infrastructure in Asia Pacific, Latin America, and Africa offers significant growth opportunities for new entrants.
- Collaborations and Partnerships: Alliances between manufacturers and research institutions can accelerate product development and regional adoption.
- Over-the-Counter Applications: The use of quinine in wellness products for muscle relaxation presents an additional revenue stream for consumer-focused pharmaceutical brands.
Regional Analysis
North America remains a stable market due to well-established healthcare systems and growing demand for muscle cramp management therapies. In Europe, aging populations and increased awareness of therapeutic alternatives contribute to consistent growth.
The Asia Pacific region is expected to register the highest growth rate over the forecast period, driven by high malaria prevalence, improving healthcare infrastructure, and increasing disposable incomes. Latin America and the Middle East & Africa are also significant contributors, supported by public health initiatives and rising awareness of preventive and curative treatments.
Key Players
The global quinine market is highly competitive, with leading companies driving innovation and expanding market reach. Prominent market players include:
- Aecochem Corp
- Haihang Industry Co. Ltd.
- Actavis
- Shreeji Pharma International
- Wockhardt
- Vital Labs
- Trademax Pharmaceuticals & Chemicals
- Van Wankum Ingredients
- Hangzhou Dayang Co. Ltd.
- IS Chemical Technology Ltd.
- Leocorno Enterprises
- Bickford & Sons
- Fever-Tree
- Schweppes
- Chempro Pharma Private Limited
These companies are focusing on strategic partnerships, product development, and regional expansions to strengthen their market positions and meet the growing global demand for quinine.
Market Segmentation
The quinine market is segmented based on type, application, administration, end user, and geographic coverage:
By Type:
- 200 mg
- 300 mg
- Other
By Application:
- Problematic Leg Cramps
- Malaria
- Other
By Administration:
- Oral Administration
- Intramuscular Administration
- Intravenous Administration
- Others
By End User:
- Hospitals
- Clinics
- Others
By Geographic Coverage:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Quinine Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Quinine Market Outlook, 2020-2033
- 3.1. Global Quinine Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 3.1.1. 200 mg
- 3.1.2. 300 mg
- 3.1.3. Other
- 3.2. Global Quinine Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Problematic Leg Cramps
- 3.2.2. Malaria
- 3.2.3. Other
- 3.3. Global Quinine Market Outlook, by Administration, Value (US$ Bn), 2020-2033
- 3.3.1. Oral Administration
- 3.3.2. Intramuscular Administration
- 3.3.3. Intravenous Administration
- 3.3.4. Others
- 3.4. Global Quinine Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Hospitals
- 3.4.2. Clinics
- 3.4.3. Others
- 3.5. Global Quinine Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Quinine Market Outlook, 2020-2033
- 4.1. North America Quinine Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 4.1.1. 200 mg
- 4.1.2. 300 mg
- 4.1.3. Other
- 4.2. North America Quinine Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Problematic Leg Cramps
- 4.2.2. Malaria
- 4.2.3. Other
- 4.3. North America Quinine Market Outlook, by Administration, Value (US$ Bn), 2020-2033
- 4.3.1. Oral Administration
- 4.3.2. Intramuscular Administration
- 4.3.3. Intravenous Administration
- 4.3.4. Others
- 4.4. North America Quinine Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Hospitals
- 4.4.2. Clinics
- 4.4.3. Others
- 4.5. North America Quinine Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Quinine Market Outlook, by Type, 2020-2033
- 4.5.2. U.S. Quinine Market Outlook, by Application, 2020-2033
- 4.5.3. U.S. Quinine Market Outlook, by Administration, 2020-2033
- 4.5.4. U.S. Quinine Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Quinine Market Outlook, by Type, 2020-2033
- 4.5.6. Canada Quinine Market Outlook, by Application, 2020-2033
- 4.5.7. Canada Quinine Market Outlook, by Administration, 2020-2033
- 4.5.8. Canada Quinine Market Outlook, by End User, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Quinine Market Outlook, 2020-2033
- 5.1. Europe Quinine Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 5.1.1. 200 mg
- 5.1.2. 300 mg
- 5.1.3. Other
- 5.2. Europe Quinine Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Problematic Leg Cramps
- 5.2.2. Malaria
- 5.2.3. Other
- 5.3. Europe Quinine Market Outlook, by Administration, Value (US$ Bn), 2020-2033
- 5.3.1. Oral Administration
- 5.3.2. Intramuscular Administration
- 5.3.3. Intravenous Administration
- 5.3.4. Others
- 5.4. Europe Quinine Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Hospitals
- 5.4.2. Clinics
- 5.4.3. Others
- 5.5. Europe Quinine Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Quinine Market Outlook, by Type, 2020-2033
- 5.5.2. Germany Quinine Market Outlook, by Application, 2020-2033
- 5.5.3. Germany Quinine Market Outlook, by Administration, 2020-2033
- 5.5.4. Germany Quinine Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Quinine Market Outlook, by Type, 2020-2033
- 5.5.6. Italy Quinine Market Outlook, by Application, 2020-2033
- 5.5.7. Italy Quinine Market Outlook, by Administration, 2020-2033
- 5.5.8. Italy Quinine Market Outlook, by End User, 2020-2033
- 5.5.9. France Quinine Market Outlook, by Type, 2020-2033
- 5.5.10. France Quinine Market Outlook, by Application, 2020-2033
- 5.5.11. France Quinine Market Outlook, by Administration, 2020-2033
- 5.5.12. France Quinine Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Quinine Market Outlook, by Type, 2020-2033
- 5.5.14. U.K. Quinine Market Outlook, by Application, 2020-2033
- 5.5.15. U.K. Quinine Market Outlook, by Administration, 2020-2033
- 5.5.16. U.K. Quinine Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Quinine Market Outlook, by Type, 2020-2033
- 5.5.18. Spain Quinine Market Outlook, by Application, 2020-2033
- 5.5.19. Spain Quinine Market Outlook, by Administration, 2020-2033
- 5.5.20. Spain Quinine Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Quinine Market Outlook, by Type, 2020-2033
- 5.5.22. Russia Quinine Market Outlook, by Application, 2020-2033
- 5.5.23. Russia Quinine Market Outlook, by Administration, 2020-2033
- 5.5.24. Russia Quinine Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Quinine Market Outlook, by Type, 2020-2033
- 5.5.26. Rest of Europe Quinine Market Outlook, by Application, 2020-2033
- 5.5.27. Rest of Europe Quinine Market Outlook, by Administration, 2020-2033
- 5.5.28. Rest of Europe Quinine Market Outlook, by End User, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Quinine Market Outlook, 2020-2033
- 6.1. Asia Pacific Quinine Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 6.1.1. 200 mg
- 6.1.2. 300 mg
- 6.1.3. Other
- 6.2. Asia Pacific Quinine Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Problematic Leg Cramps
- 6.2.2. Malaria
- 6.2.3. Other
- 6.3. Asia Pacific Quinine Market Outlook, by Administration, Value (US$ Bn), 2020-2033
- 6.3.1. Oral Administration
- 6.3.2. Intramuscular Administration
- 6.3.3. Intravenous Administration
- 6.3.4. Others
- 6.4. Asia Pacific Quinine Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Hospitals
- 6.4.2. Clinics
- 6.4.3. Others
- 6.5. Asia Pacific Quinine Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Quinine Market Outlook, by Type, 2020-2033
- 6.5.2. China Quinine Market Outlook, by Application, 2020-2033
- 6.5.3. China Quinine Market Outlook, by Administration, 2020-2033
- 6.5.4. China Quinine Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Quinine Market Outlook, by Type, 2020-2033
- 6.5.6. Japan Quinine Market Outlook, by Application, 2020-2033
- 6.5.7. Japan Quinine Market Outlook, by Administration, 2020-2033
- 6.5.8. Japan Quinine Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Quinine Market Outlook, by Type, 2020-2033
- 6.5.10. South Korea Quinine Market Outlook, by Application, 2020-2033
- 6.5.11. South Korea Quinine Market Outlook, by Administration, 2020-2033
- 6.5.12. South Korea Quinine Market Outlook, by End User, 2020-2033
- 6.5.13. India Quinine Market Outlook, by Type, 2020-2033
- 6.5.14. India Quinine Market Outlook, by Application, 2020-2033
- 6.5.15. India Quinine Market Outlook, by Administration, 2020-2033
- 6.5.16. India Quinine Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Quinine Market Outlook, by Type, 2020-2033
- 6.5.18. Southeast Asia Quinine Market Outlook, by Application, 2020-2033
- 6.5.19. Southeast Asia Quinine Market Outlook, by Administration, 2020-2033
- 6.5.20. Southeast Asia Quinine Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Quinine Market Outlook, by Type, 2020-2033
- 6.5.22. Rest of SAO Quinine Market Outlook, by Application, 2020-2033
- 6.5.23. Rest of SAO Quinine Market Outlook, by Administration, 2020-2033
- 6.5.24. Rest of SAO Quinine Market Outlook, by End User, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Quinine Market Outlook, 2020-2033
- 7.1. Latin America Quinine Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 7.1.1. 200 mg
- 7.1.2. 300 mg
- 7.1.3. Other
- 7.2. Latin America Quinine Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Problematic Leg Cramps
- 7.2.2. Malaria
- 7.2.3. Other
- 7.3. Latin America Quinine Market Outlook, by Administration, Value (US$ Bn), 2020-2033
- 7.3.1. Oral Administration
- 7.3.2. Intramuscular Administration
- 7.3.3. Intravenous Administration
- 7.3.4. Others
- 7.4. Latin America Quinine Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Hospitals
- 7.4.2. Clinics
- 7.4.3. Others
- 7.5. Latin America Quinine Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Quinine Market Outlook, by Type, 2020-2033
- 7.5.2. Brazil Quinine Market Outlook, by Application, 2020-2033
- 7.5.3. Brazil Quinine Market Outlook, by Administration, 2020-2033
- 7.5.4. Brazil Quinine Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Quinine Market Outlook, by Type, 2020-2033
- 7.5.6. Mexico Quinine Market Outlook, by Application, 2020-2033
- 7.5.7. Mexico Quinine Market Outlook, by Administration, 2020-2033
- 7.5.8. Mexico Quinine Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Quinine Market Outlook, by Type, 2020-2033
- 7.5.10. Argentina Quinine Market Outlook, by Application, 2020-2033
- 7.5.11. Argentina Quinine Market Outlook, by Administration, 2020-2033
- 7.5.12. Argentina Quinine Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Quinine Market Outlook, by Type, 2020-2033
- 7.5.14. Rest of LATAM Quinine Market Outlook, by Application, 2020-2033
- 7.5.15. Rest of LATAM Quinine Market Outlook, by Administration, 2020-2033
- 7.5.16. Rest of LATAM Quinine Market Outlook, by End User, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Quinine Market Outlook, 2020-2033
- 8.1. Middle East & Africa Quinine Market Outlook, by Type, Value (US$ Bn), 2020-2033
- 8.1.1. 200 mg
- 8.1.2. 300 mg
- 8.1.3. Other
- 8.2. Middle East & Africa Quinine Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Problematic Leg Cramps
- 8.2.2. Malaria
- 8.2.3. Other
- 8.3. Middle East & Africa Quinine Market Outlook, by Administration, Value (US$ Bn), 2020-2033
- 8.3.1. Oral Administration
- 8.3.2. Intramuscular Administration
- 8.3.3. Intravenous Administration
- 8.3.4. Others
- 8.4. Middle East & Africa Quinine Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Hospitals
- 8.4.2. Clinics
- 8.4.3. Others
- 8.5. Middle East & Africa Quinine Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Quinine Market Outlook, by Type, 2020-2033
- 8.5.2. GCC Quinine Market Outlook, by Application, 2020-2033
- 8.5.3. GCC Quinine Market Outlook, by Administration, 2020-2033
- 8.5.4. GCC Quinine Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Quinine Market Outlook, by Type, 2020-2033
- 8.5.6. South Africa Quinine Market Outlook, by Application, 2020-2033
- 8.5.7. South Africa Quinine Market Outlook, by Administration, 2020-2033
- 8.5.8. South Africa Quinine Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Quinine Market Outlook, by Type, 2020-2033
- 8.5.10. Egypt Quinine Market Outlook, by Application, 2020-2033
- 8.5.11. Egypt Quinine Market Outlook, by Administration, 2020-2033
- 8.5.12. Egypt Quinine Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Quinine Market Outlook, by Type, 2020-2033
- 8.5.14. Nigeria Quinine Market Outlook, by Application, 2020-2033
- 8.5.15. Nigeria Quinine Market Outlook, by Administration, 2020-2033
- 8.5.16. Nigeria Quinine Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Quinine Market Outlook, by Type, 2020-2033
- 8.5.18. Rest of Middle East Quinine Market Outlook, by Application, 2020-2033
- 8.5.19. Rest of Middle East Quinine Market Outlook, by Administration, 2020-2033
- 8.5.20. Rest of Middle East Quinine Market Outlook, by End User, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Aecochem Corp
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Haihang Industry Co. Ltd.
- 9.4.3. Actavis
- 9.4.4. Shreeji Pharma International
- 9.4.5. Wockhardt
- 9.4.6. Vital Labs
- 9.4.7. Van Wankum Ingredients
- 9.4.8. Hangzhou Dayang Co. Ltd.
- 9.4.9. IS Chemical Technology Ltd.
- 9.4.10. Leocorno Enterprises
- 9.4.1. Aecochem Corp
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
샘플 요청 목록